相关实验视频
Updated: Jan 24, 2026

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
29.6K
在儿科创伤性脑损伤神经药理学
Laura E Black1, Nancy Yeh1, Emily Hillaker1
1Department of Neurorehabilitation Kennedy Krieger Institute, Baltimore, MD, USA.
Journal of pediatric rehabilitation medicine
|January 23, 2026
概括
本综述探讨了治疗严重创伤性脑损伤 (TBI) 的儿童并发症的药物. 证据通常来自成人研究,突出了对TBI治疗的更多儿科特定研究的需要.
科学领域:
- 儿科神经学 儿科神经学
- 神经临界护理是指神经临界护理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有严重创伤性脑损伤 (TBI) 的儿童面临严重的医疗并发症.
- 这些并发症包括性交感性过敏,意识障碍,情绪障碍,激动和上部运动神经元综合征.
研究的目的:
- 审查用于管理儿科TBI并发症的药理学药剂.
- 评估儿童群体中这些药物的支持证据.
主要方法:
- 对儿童TBI并发症的药理学管理研究的文献综述.
- 证据强度的分析,通常是从成人TBI文献中推断出来的.
主要成果:
- 各种药理学药物用于治疗儿童TBI相关的并发症.
- 儿童TBI的许多治疗方法的证据基础有限,经常依赖成人数据.
结论:
- 目前对儿科TBI并发症的药理管理严重依赖成人数据.
- 进一步的研究是必不可少的,以建立基于证据的指导方针,用于药物使用在儿科TBI.
相关概念视频
Traumatic Memory
563
Emotionally traumatic events often lead to memories that are exceptionally vivid and enduring, sometimes persisting with remarkable clarity throughout an individual's life. A classic example of this phenomenon is a person who survives a car accident. Even years later, they may recall every detail of the event with startling accuracy — the screeching of the tires, the jarring impact, and the acrid smell of burning rubber. Such vividness contrasts sharply with how an individual...
563
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism
199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Post-traumatic Stress Disorder
499
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
499
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
260
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260

